BioMensio

About:

Biomensio is revolutionizing analytics through its Diagnostics-as-a-Service Platform.

Website: http://www.biomensio.com/

Top Investors: Business Finland, EASME - EU Executive Agency for SMEs, Siemens Technology Accelerator, VTT Ventures

Description:

Biomensio is revolutionizing analytics through its Diagnostics-as-a-Service Platform.

 The platform consists of a fully digital handheld reader, multianalyte fluid cartridges, and a cloud-based analytics service powered by professional services team. DXaaS provides an easier access for OEM partners to develop bio analysis products and services. Their initial application areas of interest are point-of-need applications including the detection of drug abuse in saliva, as well as food and milk safety.

Total Funding Amount:

6.06M EUR

Headquarters Location:

Tampere, Western Finland, Finland

Founded Date:

2015-01-01

Contact Email:

info(AT)biomensio.com

Founders:

Ilari Antila, Joni Leinvuo, Sanna Auer

Number of Employees:

11-50

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai